2011 | MD Anderson Cancer Center Skip to Content
Top

BY Scott Merville

A federal task force that gave prostate cancer screening a D grade -- as in don't screen men who have no symptoms of the disease -- should bump that rating to a C, an MD Anderson scientist argues this week in a commentary in the Journal of the American Medical Association.

A grade C more closely fits available clinical evidence and will encourage clinicians to engage men in informed decision-making, a process that the D grade is...

BY Scott Merville

MD Anderson researchers have identified molecular factors that erode the effectiveness of two important drugs for multiple...

BY Scott Merville

Adding a third drug to frontline combination therapy for acute myeloid leukemia resulted in an 85% complete remission...

BY Scott Merville

A promising new class of drugs may shift treatment of the most common form of adult leukemia from combination chemotherapies to a more customized approach.

One such B cell receptor inhibitor, called PCI-32765, continues to show improved effectiveness in an ongoing clinical trial with relatively mild side effects compared to existing treatment.

Susan O'Brien, M.D., professor in MD Anderson's Department of Leukemia, will...

BY Naoto Ueno, M.D., Ph.D., Department of Breast Medical Oncology

Inflammatory breast cancer (IBC) is one of the most aggressive subtypes of breast cancer. The MD Anderson Morgan Welch Inflammatory...

BY Naoto Ueno, M.D., Ph.D., Department of Breast Medical Oncology

Attending the San Antonio Breast Cancer Symposium for the past two years as a member of press is always a very pleasing and rewarding experience...

BY MD Anderson Staff

In an MD Anderson-led study presented at the San Antonio Breast Cancer Symposium today, researchers presented new data about a combination...

BY Scott Merville

An experimental drug that directly reduces fat by destroying the blood vessels that support it caused an 11 percent weight loss in obese rhesus...

BY Scott Merville

Powel Brown on 10 Years' Progress in Cancer Prevention

When online news service MedPage Today wanted some perspective on cancer prevention...

BY Scott Merville

The Cancer Prevention and Research Institute of Texas Wednesday awarded The University of Texas MD Anderson Cancer Center...

BY Scott Merville

A pair of proteins found to be overexpressed in a variety of cancers actually link to each other in glioblastoma multiforme. In the process...

BY Scott Merville

Some of the world's top minds in cancer research will gather this weekend to ponder new ways of ensuring that people won't ever need to seek...

BY Katrina Burton

New data released from the Selenium and Vitamin E Cancer Prevention Trial (SELECT) shows men who took daily doses of vitamin E had significantly...

BY Scott Merville

Mutations of a tumor-suppressing gene that raise a woman's risk of developing ovarian cancer actually increase her chances of surviving the...

BY Lori Baker

People across the world are mourning the death of Apple co-founder Steve Jobs, who passed away Wednesday, Oct 5, following a battle with pancreatic...

BY Scott Merville

Patients with four types of cancer have new treatment options available after approval of three new drugs by the United States Food and...

BY Scott Merville

An intravenously delivered genetic bomb primed to go off only in breast cancer cells kills tenacious breast cancer-initiating cells, MD...

BY Dana Lee

Day 2 of the Proton Therapy Center National Education Conference picks up where day 1 left off with insights into lung cancer, physics, dosimetry...

BY Dana Lee

The Proton Therapy Center National Education Conference is designed to educate healthcare professionals on the recent advances, current treatment...

BY Scott Merville

A blend of histone proteins and DNA that packs genes into chromosomes, chromatin influences gene expression, DNA repair and chromosome recombination...

BY Scott Merville

It might not be quite as hard for physically inactive people to live longer by launching an exercise program as previously thought. In a study...

BY Scott Merville

Discovery of six mutated genes in head and neck squamous cell cancer provides an opportunity to develop customized treatment for the disease...

BY Scott Merville

Cancer evades or wards off attack by the immune system and even hijacks some aspects of the body's defenses against disease to thrive and...

BY MD Anderson Staff

Publishing high-quality research is a major advantage for graduate students in today's climate of financial austerity and intense competition...

BY Scott Merville and Laura Sussman

Customized treatment that matches specialized cancer drugs to their targets on each patient's tumor has been found to increase survival of...

BY MD Anderson Staff

A new study published May 31 in the Journal of Clinical Oncology reports that beta-blocker use is associated with improved relapse-free survival...

BY Scott Merville

After years of failure in the treatment of advanced melanoma, two new drugs have emerged that help patients with one of the most deadly and...

BY Scott Merville

Like the plastic tips on shoelaces, telomeres sit at the end of chromosomes, protecting them from unraveling telomeres are protective, preventing...

BY Dawn Dorsey

A type of drug that blocks the binding of cancer-promoting proteins may be suitable for treatment-resistant non-small cell lung cancer (NSCLC...

BY Scott Merville

MD Anderson researchers followed a surprising clue to discover that a known cancer-fighting protein also limits the growth of cells damaged...